# Braeburn Capital

Braeburn Capital is an Asset Manager based in Plymouth Meeting, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Plymouth Meeting, United States
- **Region:** North America
- **Address:** 450 Plymouth Rd, Suite 400, Plymouth Meeting, PA 19462
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** braeburnrx.com

## Regulatory record

- **Reports private funds:** No

## About

At Braeburn, there are opportunities to contribute to our purpose every day. We value authenticity and strive to amplify all voices. Our culture empowers everyone to be successful and unleashes our full potential.

## Questions

### What product does Braeburn Capital commercialize?

Braeburn commercializes a long-acting injectable form of buprenorphine for treating opioid use disorder. The product is part of a category known as medication-assisted treatment. The firm promotes it through a patient-support program called Braeburn By Your Side.

### How is Braeburn Capital related to Apple Inc.'s asset-management subsidiary of the same name?

Braeburn Capital, the specialty pharmaceutical company based in Plymouth Meeting, Pennsylvania, is not related to Apple Inc.'s Nevada-based asset-management subsidiary, also called Braeburn Capital. They are separate entities sharing a name but operating in entirely different industries.

## Related profiles

- [Alvin & Fanny B. Thalheimer Foundation](https://altss.com/profile/alvin-and-fanny-b-thalheimer-foundation)
- [Nordea Asset Management](https://altss.com/profile/nordea-asset-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/braeburn-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology